4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Alexander Kolevzon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Dose Ketamine in Children With ADNP Syndrome Ketamine - ADNP Syndrome | Phase 1 / Phase 2 | Completed | Alexander Kolevzon | 10 | 2020-08-19 | 2023-07-07 |
| AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy AMO-01 - Phelan-McDermid Syndrome, Epilepsy | Phase 2 | Completed | Alexander Kolevzon | 6 | 2018-05-30 | 2025-06-27 |
| Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome Oxytocin, Saline - Phelan-McDermid Syndrome | Phase 2 | Completed | Alexander Kolevzon | 18 | 2016-04-29 | 2021-12-06 |
| The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders Syntocinon, Placebo - Autism, ASD | Phase 2 | Completed | Alexander Kolevzon | 30 | 2010-06-18 | 2021-04-15 |
Telomeric 22q13 Monosomy Syndrome (2) · Autistic Disorder (1) · Chromosome Aberrations (1) · Chromosome Disorders (1) · Epilepsy (1)
Oxytocin (2) · Ketamine (1) · Sodium Chloride (1)
United States (4)